Radionuclide Therapy (RNT)



Preliminary consultation RNT

Preliminary consultation RNT

Skeletal scintigram

Skeletal scintigram

Radionuclide therapy is a form of nuclear medical therapy; you will be injected with radioactive substances. The radiation you receive (beta radiation) has only a low range in tissues, but develops a high local impact while protecting surrounding tissues.

In the case of a number of malignant tumours (e. g. prostate carcinoma, mamma carcinoma) secondary growths develop in the bones. In many cases the pain caused by these leads to a considerable reduction in the patient's quality of life. If it is not possible to suppress the pain sufficiently using drugs, treatment with radioactive substances offers a valuable supplement in an interdisciplinary treatment concept alongside chemotherapy, surgical and radiotherapeutic methods.

This is an out-patient treatment: afterwards you will be allowed to go home.



Prerequisites to radionuclide pain therapy are good accumulation of bone metastases in the skeletal scintigram and adequate bone marrow function. For this reason, a scintigram of the skeleton as well as a full blood picture must be obtained before the therapy.

In order to plan the therapy, the nuclear physician will require reports on previous treatments and examinations; he or she will also need to know the current pain-killing drugs you are taking.



The low-level radiolabelled medication (radiotracer) will be injected into an arm vein. Depending on the results of blood tests, it may be possible to repeat the radionuclide therapy.